FSSAI has clarified that its order dated 14 October 2025 withdraws earlier permissions allowing the use of “ORS” in brand names. This overrides previous advisories from July 2022 and February 2024, which had permitted “ORS” with disclaimer.
FSSAI has issued a clarification regarding its recent order dated 14th October 2025, which withdraws previous permissions allowing the use of the term “ORS” along with brand names. This decision supersedes earlier orders from 14th July 2022 and 2nd February 2024 that had permitted the word “ORS” as part of the trademark with prefix or suffix in the product name, subject to the declaration/warning: "The product is NOT an ORS formula as recommended by WHO."
FSSAI has now clarified that using “ORS” in branding or labelling is misleading and violates several provisions of the Food Safety and Standards Act, 2006, and associated regulations on labelling, display, advertising, and claims. These practices can deceive consumers by implying medical efficacy or therapeutic benefits not substantiated by the product's nature.
The directive is issued with immediate effect and has been approved by the Competent Authority.